2016
DOI: 10.1016/j.biomaterials.2016.06.039
|View full text |Cite
|
Sign up to set email alerts
|

HB-EGF embedded in PGA/PLLA scaffolds via subcritical CO 2 augments the production of tissue engineered intestine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
27
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 66 publications
0
27
0
Order By: Relevance
“…We anticipated that the immobilized bFGF should be more active to boost growth of NIH‐3T3 cells due to its expanded duration of effect. As highlighted in majority of recent studies, the immobilized growth factors have been confirmed to be positive in cell functions and tissue regeneration both in vitro and vivo environments . However, only a few researches explored the stimulation of cells by growth factors which could be immobilized on surfaces of biomaterials at certain densities of growth factors.…”
Section: Resultsmentioning
confidence: 99%
“…We anticipated that the immobilized bFGF should be more active to boost growth of NIH‐3T3 cells due to its expanded duration of effect. As highlighted in majority of recent studies, the immobilized growth factors have been confirmed to be positive in cell functions and tissue regeneration both in vitro and vivo environments . However, only a few researches explored the stimulation of cells by growth factors which could be immobilized on surfaces of biomaterials at certain densities of growth factors.…”
Section: Resultsmentioning
confidence: 99%
“…Histocompatibility, one of the most important properties of biomaterials, can be tested by subcutaneous implantation into the peritoneum of rats. PLLA and PA have received much attention for biomaterial production and have been approved by the FDA for use in vivo. These polymers have a low immune response after being implanted into the body.…”
Section: Discussionmentioning
confidence: 99%
“…Despite advances in the understanding of the etiology and pathophysiology of NEC, neonatologists remain frustrated by the dearth of tools for early definitive diagnosis, the paucity of preventive strategies, and the absence of specific treatment modalities. Gut organoid systems, tissue‐engineered intestinal epithelial platforms, and newer tools to study the ENS offer exciting avenues to gain novel mechanistic insights into epithelial barrier function, ENS, and immune function and the impact of the microbiome . Various novel biomarkers have shown promise in prediction and diagnosis.…”
Section: Ongoing Challenges and Summarymentioning
confidence: 99%